BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26100546)

  • 1. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.
    Streiff MB; Ye X; Kickler TS; Desideri S; Jani J; Fisher J; Grossman SA
    J Neurooncol; 2015 Sep; 124(2):299-305. PubMed ID: 26100546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.
    Semrad TJ; O'Donnell R; Wun T; Chew H; Harvey D; Zhou H; White RH
    J Neurosurg; 2007 Apr; 106(4):601-8. PubMed ID: 17432710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism and survival in patients with high-grade glioma.
    Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
    Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
    Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
    Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
    Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
    Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
    Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
    Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoma and venous thromboembolism: influence on mortality.
    Mahajan A; Wun T; Chew H; White RH
    Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.
    Giorgi Pierfranceschi M; Donadini MP; Dentali F; Ageno W; Marazzi M; Bocchi R; Imberti D
    Thromb Haemost; 2013 Jan; 109(1):34-8. PubMed ID: 23223906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
    Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.
    Thaler J; Ay C; Kaider A; Reitter EM; Haselböck J; Mannhalter C; Zielinski C; Marosi C; Pabinger I
    Neuro Oncol; 2014 Dec; 16(12):1645-51. PubMed ID: 24987133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
    Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
    Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
    Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period.
    Smith TR; Lall RR; Graham RB; Mcclendon J; Lall RR; Nanney AD; Adel JG; Zakarija A; Chandler JP
    J Neurooncol; 2014 Nov; 120(2):347-52. PubMed ID: 25062669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period.
    Watanabe J; Natsumeda M; Okada M; Kanemaru Y; Tsukamoto Y; Oishi M; Kakita A; Fujii Y
    World Neurosurg; 2019 Aug; 128():e982-e988. PubMed ID: 31100523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Venous Thromboembolism in Patients with Glioblastoma.
    Nabi S; Kahlon P; Bozorgnia F; Arshad A; Mikkelsen T; Donthireddy V
    Pathol Oncol Res; 2016 Apr; 22(2):311-6. PubMed ID: 26547860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
    Holmqvist ME; Neovius M; Eriksson J; Mantel Ä; Wållberg-Jonsson S; Jacobsson LT; Askling J
    JAMA; 2012 Oct; 308(13):1350-6. PubMed ID: 23032551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.